Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai

Fudan University Shanghai Cancer Center, Shanghai

Fudan University Zhongshan Hospital, Shanghai

Shanghai General Hospital, Shanghai

Tianjin Hospital, Tianjin

Jiangxi Cancer Hospital, Nanchang

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

Sun Yat-Sen University Cancer Center, Guangzhou

Gansu Cancer Hospital, Lanzhou

The 1st Affiliated Hospital of Bengbu Medical College, Bengbu

Beijing Cancer Hospital, Beijing

Peking Union Medical College Hospital, Beijing

The First Affiliated Hospital of Fujian Meidical University, Fuzhou

The First Affiliated Hospital of Sun Yat-sen university, Guangzhou

Guangxi medical university affiliated tumor hospital, Nanning

Harbin medical university affiliated tumor hospital, Harbin

Henan Province Tumor Hospital, Luoyan

Hunan Province Tumor Hospital, Changsha

Liaoning Province Tumor Hospital, Shenyang

Shanghai 6th People's Hospital, Shanghai

The First Affiliated Hospital of Xian Jiaotong University, Xian

West China Hospital , Sichuan University, Chengdu

Tianjin Medical University Cancer Hospital, Tianjin

The Third Hospital of hebei Medical University, Shijiazhuang